Increasing diagnostic accuracy to grade dysplasia in Barrett’s esophagus using an immunohistochemical panel for CDX2, p120ctn, c-Myc and Jagged1

BACKGROUND: Patients with non-dysplastic Barrett’s esophagus (ND-BE) and low-grade dysplasia (LGD) are typically monitored by periodic endoscopic surveillance, while those with high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC) are usually treated by more aggressive interventions like en...

Descripción completa

Detalles Bibliográficos
Autores principales: Karamchandani, Dipti M., Lehman, Heather L., Ohanessian, Sara E., Massé, Julie, Welsh, Patricia A., Odze, Robert D., Goldblum, John R., Berg, Arthur S., Stairs, Douglas B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772649/
https://www.ncbi.nlm.nih.gov/pubmed/26926447
http://dx.doi.org/10.1186/s13000-016-0473-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772649/
https://www.ncbi.nlm.nih.gov/pubmed/26926447
http://dx.doi.org/10.1186/s13000-016-0473-7

Ejemplares similares